text.skipToContent text.skipToNavigation

インドネシアのお客様のみへの通知  詳細を見る
カスタマーサポートの連絡先:
pim.indonesia.contact.title2
Layanan Pengaduan Konsumen

(Business Unit Performance Materials, Sales Support Team)

pim.indonesia.contact.address

Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia

+62 21 2988 8557

[email protected]

Direktorat Jenderal Perlindungan Konsumen dan Tertib Niaga Kementerian Perdagangan Republik Indonesia
0853 1111 1010

成功!お問い合わせは営業チームに送信されました。

何か問題が発生しました! しばらくしてからお試しください。

  • /_ui/responsive/common/custom/images/default-supplier-banner-1.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-2.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-3.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-4.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-5.jpg

AARTI DRUGS

Aarti Drugs Ltd., established in 1984, is a key player in the Aarti Group of Industries, with a total group value of $900 million. They operate in the pharmaceutical sector, producing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, and Formulations through their subsidiary, Pinnacle Life Science Private Limited. Their product range includes various pharmaceutical ingredients and specialty chemicals. The company is known for its quality manufacturing and holds Good Manufacturing Practices (GMP) certifications. They are also in the process of securing ISO 9002 compliance. With government initiatives promoting private health insurance, Aarti Drugs Ltd. aims to expand its market presence by offering high-quality products with timely delivery, capitalizing on the expected growth in the generic pharmaceutical sector.

 

メディアギャラリー

商品数量を更新しました。